Status:
RECRUITING
Effect of ınhaler Use on Oral Health in COPD Patients
Lead Sponsor:
Çankırı Karatekin University
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
35-80 years
Phase:
NA
Brief Summary
The aim of this study was to evaluate the effect of oral health education given to individuals diagnosed with COPD and using inhaled medication.
Detailed Description
Before the research data are collected, the purpose, content, scope and duration of the research will be explained in one-to-one interviews with the participants. Verbal and written informed consent w...
Eligibility Criteria
Inclusion
- Diagnosed with COPD for at least 6 months,
- Outpatient and inpatient,
- Consent to participate in the research,
- Not under the age of eighteen,
- With a metered dose inhaler (MDI) in treatment,
- No communication barriers,
- No COPD exacerbation and/or respiratory tract infection,
- According to the GOLD report; mild (Stage 1), moderate (Stage 2), severe (Stage 3).
Exclusion
- Diagnosed with COPD for less than 6 months,
- Refused to participate in the research,
- Treatment without metered dose inhalers (MDIs),
- Uncommunicative,
- Those who withdrew from participating in the study during data collection,
- Not completing the survey,
- COPD exacerbation and/or respiratory tract infection,
Key Trial Info
Start Date :
May 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07000604
Start Date
May 30 2025
End Date
October 30 2025
Last Update
June 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Çankiri Devlet Hastanesi
Çankırı, Turkey (Türkiye), 18000